Company intelligence / Profile preview

Rock Creek Pharmaceuticals

Sarasota, Florida, United Statesprnewswire.com ↗

Ownership: Private
Development stage: Phase 2

Overview

All pipeline programs were in preclinical or discovery stages for various chronic inflammatory and neurologic conditions at the time the company ceased operations. No clinical results were reported.

Therapeutic areas: GastroenterologyPsychiatryRheumatologyImmunologyEndocrinologyDermatologyNeurology
Modalities: Small molecules (notably anatabine citrate)
Industry: Biotech

Drug pipeline

1 asset

anatabine

Beyond the preview

Go deeper on Rock Creek Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rock Creek Pharmaceuticals.

Explore the full profile